Oral administration of S-nitroso-N-acetylcysteine prevents the onset of non alcoholic fatty liver disease in rats

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 12

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

314

HTML

2838

Figures (1-5)

150

Tables (1-1)

143

Sum=3445

Mar 28, 2006 (publication date) through Jul 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Mar 28, 2006; 12(12): 1905-1911
Published online Mar 28, 2006. doi: 10.3748/wjg.v12.i12.1905

Full Size Figure Download Figure

Figure 2 Concentration of hydroperoxides (LOOH) in liver homogenates of the control group, NAC and SNAC-treated animals.

Citation: Oliveira CP, Simplicio FI, Lima VM, Yuahasi K, Lopasso FP, Alves VA, Abdalla DS, Carrilho FJ, Laurindo FR, Oliveira MG. Oral administration of S-nitroso-N-acetylcysteine prevents the onset of non alcoholic fatty liver disease in rats. World J Gastroenterol 2006; 12(12): 1905-1911
URL: https://www.wjgnet.com/1007-9327/full/v12/i12/1905.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i12.1905